Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 2,020 shares at $11.30 ($22K) on 2025-05-14, disclosed to the SEC on 2025-05-16.
Scheduled sale ($22k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.30 | 20 | $226 | 1.0% |
| 2 | $10.68 | 2,000 | $21K | 99.0% |
| Total | $10.69 avg | 2,020 | $22K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-14 | $44K | — | Filing → |